Bcl2 Binding component 3 (BBC3) Rabbit Polyclonal Antibody
Frequently bought together (2)
Transient overexpression lysate of BCL2 binding component 3 (BBC3), transcript variant 4
USD 436.00
Other products for "Bcl2 Binding component 3"
Specifications
| Product Data | |
| Applications | WB |
| Recommended Dilution | Immunocytochemistry/ Immunofluorescence: 1:20-1:100, Western Blot: 2-4 ug/ml |
| Reactivities | Human |
| Host | Rabbit |
| Isotype | IgG |
| Clonality | Polyclonal |
| Immunogen | A synthetic peptide made to a region within the C-terminus of the human PUMA protein sequence (between residues 150-193). |
| Formulation | Tris-glycine, 150 mM NaCl, 0.05% sodium azide |
| Concentration | lot specific |
| Purification | Immunogen affinity purified |
| Conjugation | Unconjugated |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Gene Name | BCL2 binding component 3 |
| Database Link | |
| Background | A novel gene PUMA (p53 upregulated modulator of apoptosis) is a target for activation by the p53 tumor-suppressor gene. p53 functions as a transcriptional activator, and influences p53-inducible genes that play a role in the induction of apoptosis in response to p53. Antisense inhibition of PUMA expression reduced the apoptotic response to p53, and PUMA is likely to play a role in mediating p53-induced cell death through the cytochrome c/Apaf-1-dependent pathway. |
| Synonyms | JFY-1; JFY1; PUMA |
| Reference Data | |
| Protein Families | Druggable Genome |
| Protein Pathways | Huntington's disease, p53 signaling pathway |
Documents
| Product Manuals |
| FAQs |
| SDS |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Germany
Japan
United Kingdom
China